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Abstract. A  140,000-D protein cell surface antigen 
(140k) complex has been implicated in fibronectin- 
mediated cell-substratum attachment. We have used 
three different experimental systems to evaluate the 
hypothesis that this  140k complex can function as a 
fibronectin receptor. A monoclonal antibody that 
binds to the  140k complex specifically inhibits the 
direct binding of 3H-labeled 75,000-D fibronectin cell- 
binding fragment (f75k) to chicken embryo fibroblasts 
in suspension. The 140k complex is retarded in its 
passage through an affinity column consisting of im- 
mobilized f75k, and this interaction is specifically in- 
hibited by a synthetic peptide that contains the fibro- 
nectin cell-recognition signal sequence. Finally, exoge- 
nous purified 140k complex inhibits the attachment 
and spreading of chicken embryo fibroblasts on fibro- 
nectin-coated substrates. Thus, our results indicate 
that the  140k complex can bind directly to fibronectin 
and is likely to be a fibronectin receptor for chicken 
cells. 
T 
HE attachment of cells to extracellular matrices is an 
important interaction that plays a role in such in vivo 
biological processes as wound healing, embryonic de- 
velopment, and disease  (reviewed in references 11,  38, and 
40).  However, the  molecular mechanisms  involved in  cell 
attachment  are  still  poorly understood.  One  experimental 
strategy has been to analyze in detail the function of purified 
components of the extracellular matrix. As one of the best- 
characterized noncollagenous components of  the extracellular 
matrix, fibronectin is a valuable model system with which to 
study cell-substratum interactions ( 19, 26, 29, 34, 41). 
The interaction of fibronectin with  fibroblastic cells  has 
been examined using intact fibronectin (1,  13), defined cell- 
binding fragments of fibronectin (3),  synthetic peptides de- 
rived from the fibronectin primary structure (2,  30-32, 42, 
43), and fibronectin-coated beads (24). The direct binding of 
soluble fibronectin to cells occurs with only moderate affinity 
(Kd of 0.8 ~M, reference 1). Such binding studies indicate the 
presence of a minimum of 105 fibronectin receptors per cell, 
suggesting that such a molecule is a major cell surface com- 
ponent. As judged by inhibition and cell attachment assays, 
the minimum cellular recognition signal  on fibronectin for 
fibroblasts is a tetrapeptide with the sequence Arg-Giy-Asp- 
Ser (2, 30-32, 42, 43). This sequence is found in the fibronec- 
tin primary structure at a location that is very likely to be at 
a/3-turn, suggesting that it is an exposed site (32, 43); this site 
may become even more exposed upon cleavage of the mole- 
cule, accounting for the higher apparent affinity of certain 
defined cell-binding fragments for cells (1, 20, 21). 
Another approach towards understanding cell-extracellular 
matrix interactions has been to produce antibodies against 
cell surface antigens that have activity in altering the mor- 
phology and adhesion of cells cultured on extracellular ma- 
terials (4-10,  15, 22, 27). One of the earliest such antibodies 
to be reported (10), which has subsequently been implicated 
in fibronectin-mediated cell adhesion, is a monoclonal anti- 
body Greve and  Gottlieb designated JG22; the hybridoma 
was later extensively subcloned to produce the line designated 
JG22E  ~  (6, 7,  15). 
JG22E identifies a complex of integral membrane compo- 
nents designated as a  140,000-D  protein cell surface antigen 
(140k).  The 140k complex consists of three glycoproteins of 
apparent molecular size  155,000,  135,000,  and  120,000  D 
(15). Both JG22E and polyclonal antibodies against  purified 
140k co-distribute in chicken embryo fibroblasts (CEF) with 
fibronectin fibrils at cell adhesion sites. Furthermore, JG22E 
inhibits the attachment and spreading of CEF on fibronectin 
substrates,  and JG22E itself coated on substrates can mediate 
cell  attachment  and  spreading,  thus  demonstrating  direct, 
specific binding to a cell surface component (7). 
Other monoclonal antibodies have been independently iso- 
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antigens that are probably related or identical to 140k (4,  5, 
8, 9, 22, 27).  By a  nonimmunological approach, a glycopro- 
tein of similar size that has several properties expected of a 
fibronectin receptor has been isolated from human cells by 
affinity chromatography with  a  120,000-D  fibronectin cell- 
binding fragment (33). 
Although the data to date have been suggestive,  there is as 
yet  no  complete,  direct  evidence  that  any  of these  140k 
complexes function  as  fibronectin  receptors.  The  antigens 
that were identified immunologically as being necessary for 
cell  adhesion  have  never been  shown  to bind  fibronectin. 
Conversely, there is no evidence as yet that the cell  surface 
molecules that bind to fibronectin in vitro are required for 
cell adhesion by living cells. In this study we investigate the 
nature of the interaction between the  140k complex and the 
75,000-D fibronectin cell-binding fragment (f75k) and pro- 
vide evidence that 140k can serve as a fibroblast cell surface 
fibronectin receptor. 
Materials and Methods 
Materials 
Monoclonal antibody JG22E and the 140k complex were purified as described 
(7,  15). The purity  of the  140k complex  was routinely  analyzed by sodium 
dodecyl sulfate gel electrophoresis using 4% stacking and 7.5% resolving gels 
(7, 15). As we described previously, our 140k preparations stained by Coomassie 
Blue appear as three major bands of 120,000, 135,000, and  155,000 D under 
nonreducing  conditions  (7,15). Occasionally, a minor band of 167,000 D is 
also observed  (7,  15). 140k and  control  proteins  for spreading  assays were 
dialyzed against Dulbecco's  phosphate-buffered  saline (PBS) (GIBCO, Grand 
Island, NY) without  Ca  ÷+ or Mg  ÷÷ for 2 d and then against PBS containing 
Ca  ++ and  Mg  ÷÷ for  1 d  to remove  detergent.  The f75k  was prepared  from 
purified fibronectin  and tritium  labeled as described (1,  3,  17,  25,  36). The 
f75k and bovine serum albumin (BSA) (Calbiochem-Behring Corp., La Jolla, 
CA) were coupled separately at a ratio of 10 mg protein to 1 g dry cyanogen 
bromide-activated  Sepharose (Pharmacia,  Uppsala,  Sweden). CEF were pre- 
pared from 9-d embryos as described (39). All cells were maintained  in culture 
for no more than five passages. All synthetic peptides were custom synthesized 
to our specifications by Peninsula Laboratories, Inc. (Belmont, CA). The purity 
of  the peptides was confirmed by amino acid analysis and by high performance 
liquid chromatography  (>98%  pure). The concentrations  of all proteins were 
estimated by the method of Lowry et al. (23) using crystalline BSA as a standard. 
Binding Assay 
The direct  binding  assay for CEF  was adapted  from a  protocol  established 
earlier  for  baby  hamster kidney  ceils grown  in  suspension  culture  (1-3). 
Subconfluent CEF were collected from 175-cm  2 culture flasks by washing three 
limes in Hanks" balanced salt solution  (GIBCO), followed by brief treatment 
with  1 ml of 0.1  mg/ml crystalline trypsin (Worthington  Biochemical Corp., 
Freehold, MA) in Hanks' balanced salt solution. After 1 min, trypsin activity 
was quenched  by the addition  of serum-containing  growth medium (39). The 
cells were washed twice in binding medium and assayed for [3H]f75k binding 
as described (1,  3).  Based on earlier studies (1,  28,  37), fibronectin  receptor 
function  is  not  adversely affected by  this  concentration  of protease  in the 
presence of calcium. Furthermore,  the  140k complex itself is also resistant to 
proteases (Hasegawa, T., and K. M. Yamada,  unpublished data). 
Cell Spreading Assays and Inhibition by 
Purified 140k 
Quantitation  of fibronectin-mediated  cell spreading of CEF was performed by 
a modification of a previously described method (42). Multiwell tissue culture 
dishes (0.32 cm  2, Costar, Data Packaging Corp., Cambridge, MA) were prein- 
cubated with  100 ,ul of 1 ug/ml human plasma fibronectin in PBS containing 
Ca *+ and Mg  ÷÷ for 60 rain at room temperature  and blocked with I00/A of 10 
mg/ml heat-denatured  (80*C for 3 min) BSA in PBS without Ca  ÷* or Mg  *÷ for 
30  min.  The wells were washed seven times  with PBS containing  Ca  ÷* and 
Mg  ÷÷ after each incubation.  Subeonfluent CEF were dissociated with  100 ug/ 
ml TPCK  trypsin (Worthington  Biochemical Corp.) in PBS containing  Ca  ÷* 
and Mg  +÷ for 2 min, and tryptic activity was blocked by an excess of growth 
medium (39) before centrifugation. The cells were incubated in growth medium 
for 15 rain at 37"C and washed in PBS containing Ca  *÷ and Mg  ÷+. Cells (4 × 
103) were  incubated  in  each  welt at  37"C with  or without  I40k,  BSA, or 
fibrinogen (Sigma Chemical Co., St. Louis, MO) in PBS containing Ca ++ and 
Mg  ++ for 35  rain.  After this attachment  period, the cells were fixed with 3% 
glutaraldehyde and 3% paraformaldehyde in 0.1 M cacodylate, pH 7.4 (Electron 
Microscopy Sciences, Fort Washington,  PA) for 60  rain.  Cell spreading was 
quantitated  either as described (12, 14) or by measuring the areas of the cells 
as follows. Phase contrast  microscope fields were photographed  and enlarged 
by a factor of 1.5. The images of cells were excised from the enlarged micro- 
graphs and areas were quantitated  by weighing to the  nearest 0.01 mg using 
calibration  squares representing areas of 2,500 um  2. The calibration  squares 
weighed 27.25 _+ 0.77 mg (n = 4, _+ SEM). 
Affinity Chromatography 
The interaction of  the 140k complex with fibronectin was assayed using purified 
f75k immobilized on Sepharose beads. The f75k-Scpharose or BSA-Sepharose 
control was packed in 0.29 × 28-cm polypropylene columns and equilibrated 
with column buffer consisting of 40 mM/~-octylglucopyranoside (Calbiochem- 
Behring Corp.) in PBS. In some cases, 1 mg/ml of the synthetic peptides with 
the sequence  Gly-Arg-Gly-Asp-Ser (GRGDS)  or the sequence Gly-Arg-Gly- 
Glu-Ser  (GRGES)  was added  to the column buffer  and the  140k complex 
sample was preequilibrated  with  1.5 mg/ml peptide. The molecular weight of 
GRGES  is 3%  larger than that of GRGDS,  so concentrations  of the  former 
peptide were always adjusted to be equal to the molar concentration of  GRGDS 
when used in experiments directly comparing the effects of the two peptides. 
The  140k complex was added to columns in a total volume of 90/al either 
as purified material or as a CEF extract. The CEF extract was prepared fresh 
daily as follows: a 75-cm  z flask of confluent or subconfluent CEF was washed 
three times with PBS at 37"C. The cells were then extracted on ice for 10 rain 
with 1 ml ice-cold extraction  buffer consisting of 200 mM B-octylglucopyran- 
oside and 3 mM phenylmethylsulfonyl fluoride in PBS. The extraction  buffer 
was freshly prepared for each flask of  cells, and new flasks of  cells were extracted 
for each pair of column runs. The CEF extract was clarified by centrifuging at 
40,000 g for 20 min at 4°C, diluted to  100 mM/3-octylglucopyranoside  with 
ice-cold PBS. and applied  to the affinity column. Chromatography  was per- 
formed at a  flow rate of 0.9  ml/h, and 90 ul fractions  were collected. Each 
fraction was assayed for 140k by spotting 3-~1 aliquots on nitrocellulose grids 
prepared by drawing  l-cm squares on filter paper (0.45 um BA85, Schleicher 
& Schuell, Inc., Keene, NH) with a soft pencil. The dotted nitrocellulose sheets 
then  were incubated  in 5%  (wt/vol)  BSA (fraction  V, Miles Scientific Div., 
Naperville, IL) in 0.15 M NaCI, 0.01 M Tris-HCl, pH 7.0 (Tris-saline) either 
overnight at  room temperature  or for 90  min at 37"C. All subsequent  steps 
were performed at room temperature (22-24*C). The dot blots were incubated 
in a  1/200 dilution of polyclonal rabbit antibody to 140k in 5% BSA in Tris- 
saline for 90  min.  The blot was then  rinsed briefly in Tris-saline, incubated 
twice in Tris-saline for 10 rain, rinsed in 0.1% Tween-80 (Sigma Chemical Co.) 
in Tris-saline, incubated four times in 0.1% Tween-80 in Tris-saline for 10 min 
each, and finally incubated two times in Tris-saline for 10 rain each. The blot 
was then incubated  in  5%  BSA in Tris-saline for 5 min, then with 5 ×  105 
cpm/ml ~251-1abeled protein A (New England Nuclear, Boston, MA) in 5% BSA 
and Tris-saline for 30 min. The blot was then washed as described above and 
dried. The 140k complex was then visualized by exposing Kodak X-Omat film 
to the blot using a Quanta III enhancing screen (DuPont Co.~ Wilmington, DE) 
for  12-16  h at  -80"C.  Radioactivity  was quantitated  by excising each  spot 
along the pencil lines and counting  using an LKB-Wallac 1275 Mini-gamma 
counter (LKB  Instruments,  Inc.,  Gaithersburg,  MD).  For each  blot,  4-10 
squares were counted as blanks. In separate controls, the accuracy of the assay 
was periodically reexamined by spotting a dilution  series of 1401< complex or 
CEF extract onto nitrocellulose and measuring as described above. 
Results 
Inhibition of  Direct Binding 
[3H]f75k can be used as a probe of the fibronectin receptor 
on CEF by binding directly to these cells in suspension. The 
observed binding was greater than 80%  specific as judged by 
competition experiments with 100-fold excess unlabeled f75k 
(Fig.  1, lane B). Monoclonal antibody JG22E inhibited 75% 
of the bindng of [3H]f75k to these cells (Fig.  1, lane C). As 
JG22E does not bind to fibronectin (6, 7), this result indicates 
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Figure 1 . Inhibition ofdirect binding of ['H)f75k toCEF by JG22E.
CEF and ['H]f75k (4.5 x 10' cpm/mg) were mixed at final concen-
trations of 1 .5 x 107/ml and 30 jug/ml, respectively, in a total volume
of400 jul in the presence of no additives (A), 3 mg/ml unlabeled f75k
(B), 1 .5 mg/ml JG22E (C), or 3 mg/ml unlabeled f75k and 1 .5 mg/
ml JG22E (D) for 60 min at 22°C . The amount of cell-bound
radioactivity was determined after washing 100-g1 aliquots of cells as
described in reference 1 . Each bar represents average values (n = 3)
± SEM.
that JG22E can inhibit direct fibronectin binding to CEF by
blocking an active site on 140k . We saw no further decrease
of ['H]f75k binding to CEF when both unlabeled f75k and
JG22E were added simultaneously to the cells (Fig . 1, lane
D) . Therefore, the inhibitory effects of the monoclonal anti-
body and the fibronectin fragment were not additive, thus
confirming the interpretation that both JG22E and ['H]f75k
bind to the same cell surface component, i.e ., a fibronectin
receptor. In a separate control, normal mouse IgG had no
effect on the binding of [3H]f75k toCEF .
Interaction of140k with Immobilized)75k
Whereas detergent extracts ofhuman cells (33) and hamster
cells (Akiyama, S . K., andK. M . Yamada, unpublished data)
contain a cell surface component(s) that appears to bind to
immobilized fibronectin cell-binding fragments even after
extensive washing, we could obtain no evidence for the exist-
ence of a similar membrane component from cultured CEF
(not shown) . We therefore compared the elution rates of 140k
in CEF extracts through f75k-Sepharose columns and iden-
tical control BSA-Sepharose columns (Fig . 2). Under condi-
tions where the 140k complex elutes from the BSA column
in a nearly symmetrical peak spanning 17 fractions, the 140k
complex eluted from a f75k column in a wide, trailing peak
covering 46 fractions, indicating that even though tight bind-
ing was not occurring, a weak interaction between 140k and
f75k was observed . This weak interaction produced a retar-
dation of both the leading and the trailing edges of the peak
and as well as a decrease in the absolute height of the peak .
This result was reproducible in multiple runs and was not due
to unequal loads applied to the two types ofcolumn : the total
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peak areas of the two elution profiles were equal with 2%
error.
The specificity of the 140k-f75k interaction was assessed
using two synthetic peptides. The peptide GRGDS contains
the recognition signal for themammalian fibronectin receptor
(2, 30-32, 42, 43), and a similar peptide has been used to
elute a possible human fibronectin receptor from a fibronectin
affinity column (33) . As shown in Fig. 3 a, equilibrating the
column and the CEF extract with GRGDS and eluting in the
presence of GRGDS abolished the retardation of both the
leading and trailing edges of the 140k peak. The peak was
more symmetrical and the peak height was increased, becom-
ing very similar to the elution profile of 140k on the inert
BSA affinity column .
The effect of GRGDS was specific . We compared the
elution of 140k in the presence of 1 mg/ml GRGDS and in
the presence of an equimolar concentration of the peptide
GRGES ; a related control peptide did not elute a proposed
mammalian fibronectin receptor from fibronectin (33). As
shown in Fig . 3 b, the 140k peak trailed noticeably in the
presence ofGRGES, indicating that this control peptide has
no effect on the interaction of 140k withPA . The peak was
quite asymmetrical and very similar to the peak in the f75k
column in Fig. 2 .
To exclude possible effects of other cellular components in
the CEF homogenates on the interaction of 140k with fibro-
nectin, the column retardation assay was repeated using 3 ug
of purified 140k in the presence ofGRGDS and GRGES. As
shown in Fig . 4, purified 140k was retarded in a broad
asymmetrical peak on immobilized f75k in the presence of
GRGES . However, in the presence of GRGDS, the 140k-
f75k interaction was inhibited, and the peak was narrower,
taller, and more symmetrical. Thus, the results shown in Fig.
3 were due only to the direct interaction of 140k contained
in the CEF extract with f75k coupled to Sepharose .
Figure 2. Elution profile of 140k on f75k- and BSA-Sepharose col-
umns . A CEF detergent extract was chromatographed on columns of
immobilized f75k (*) or BSA (p) . Column conditions and quanti-
tation are described in Materials and Methods . The stippled area
indicates the relative loss of 140k in the leading peak on the f75k
column compared with the BSA column. The hatched area indicates
the degree of retardation of 140k observed on the f75k column
compared with the BSA column, indicating an interaction between
140k and f75k.
444Figure 4 . Elution profile of purified 140k on f75k-Sepharose . Puri-
fied 140k (3 tag) was equilibrated with 1.5 mg/ml GRGDS (O) or an
equimolaramount ofGRGES (0) andchromatographed on an f75k-
Sepharose affinity column equilibrated with 1 mg/ml ofthe respective
peptide. Both the leading edge and the initial peak (stippled) and the
trailing edge (hatched) were retarded in the presence of GRGES, and
GRGDS inhibited this retardation .
Inhibition ofCell Spreading by Purified 140k
CEF can attach and spread on fibronectin-coated substrates .
As shownin Fig. 5, ~70% of the cells spread on plastic coated
with 1 ug/ml fibronectin . This cell spreading could be inhib-
ited in a concentration-dependent manner by purified 140k .
At 20 Ag/ml, 140k inhibited ---30% of the fibronectin-media-
ted cell spreading as measured by counting the percentage of
spread cells (Fig. 56). At 90 jug/ml 140k, this inhibition
increased to -50% . Theinhibition appeared to be specific for
140k, since neither equimolar concentrations of BSA nor
fibrinogen showed any inhibitory activity (Fig . 56) .
Spreading as quantitated by measuring the areas of cells
rather than as the percentage of spread cells appeared to be a
more sensitive indicator of inhibition by purified 140k . In
Fig . 5, A, treatment with 20 ug/ml purified 140k resulted in
adecrease in the area coveredby the cellsshown inB to only
21% that of the control (data in Fig. 5 legend) . Fibronectin-
mediated cell spreading quantitated by measuring cell areas
was also not significantly inhibited by BSA (C) or fibrinogen
(D) .
The data shown in Fig . 5, A and B, represent the results of
a typical inhibition experiment . In multiple experiments using
different preparations of 140k, we could usually obtain ap-
proximately this level of inhibition . However, in a small
number of experiments, >50% inhibition was observed by
the criterion of percentage of cells spread, and in one experi-
ment >90% inhibition was observed . As might be expected
for a system involving competitive inhibition (see references
3 and 42), the inhibition by 140k was substantially less if
higher quantities of fibronectin were adsorbed onto the sub-
strate (not shown).
Discussion
Figure 3 . Specificity of the 140k-f75k interac-
tion . (a) A CEF detergent extract waschromat-
ographed on f75k-Sepharose alone (") or in the
presence of 1 mg/ml of GRGDS (O), as de-
scribed in Materials and Methods . (b) A CEF
detergent extractwaschromatographedon f75k-
Sepharose in the presence of GRGDS (O) or
GRGES(9) as described in Materials and Meth-
ods . In both a and b, GRGDS inhibited the
interaction between 140k and the immobilized
fibronectin fragment . The stippled area indicates
the increase of material in the leading peak in
the presence of GRGDS, and the hatched area
indicates the retardation of the trailing edge of
the peak in the absence ofGRGDS (a) and in
the presence ofGRGES (b) .
We have shown by the three following independent criteria
that the 140k complex can act as a fibronectin receptor . (a)
JG22E inhibited the binding of ['H]f75k to CEF in suspen-
sion to approximately the same extent as a 100-fold excess of
unlabeled f75k .A mixture of unlabeled f75k and JG22E did
not inhibit binding to a greater extent than either protein
alone, indicating that they were both binding to the same cell
surface component. As fibronectin cell-binding domains pre-
sumably bind to fibronectin receptors (1-3, 33), our results
suggest that 140k is also a fibronectin receptor. (b) The 140k
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Akiyama et al . 140k Cell Sur/ace Antigen Binds to FibronectinFigure  5.  (A) Inhibition of CEF attachment and spreading on fibronectin substrates by purified exogenously added  140k. CEF were allowed 
to attach and spread on substrates precoated with  1 izg/ml fibronectin in the presence of purified 140k or the control proteins albumin or 
fibrinogen. The phase contrast micrographs show CEF assayed in the presence of control buffer (a), 20 ~g/ml dialyzed 140k (b), 90 ~g/ml BSA 
from which detergent was removed by dialysis in parallel with the  140k sample (c), control buffer duplicate (d), 90/~g/ml dialyzed 140k (e), 
and 90 t~g/ml dialyzed human fibrinogen (f). The average (___ SEM) surface area of the cells is 1,280 -4- 200 tLm  2 (a), 270 ___ 80 um  2 (b), 990 +_ 
120 um  2 (c),  1,240 +  190 ~m  2 (d), 310 _  90 ~m  2 (e), and 1,090 -+ 130 ~na  2 (f). Inhibition at both 20 ~g/mt (b) and 90 ~g/ml  140k (e) is 
statistically significant compared with controls (P <  0.001),  whereas the difference between the inhibition at 20 #g/ml and 90 ug/ml 140k is 
not statistically significant (P > 0.5). Bar, 50 ~m. (B) Quantitation of inhibition  of CEF spreading by purified 140k by counting the percentage 
of spread cells. Cells on substrates precoated with 1 #g/ml fibronectin were incubated in the presence of purified, dialyzed 140k at 3, 20, or 90 
ug/ml, or with controls consisting of control PBS buffer (Con), 90 ug/ml BSA, or 90 #g/ml human fibrinogen (Fbgn). Bars indicate the mean 
___ SEM of eight random phase contrast microscopy fields per point; a total of 800 cells were scored for each point. Quantitation  of cell spreading 
was performed as described in references 12 and 14. There is no significant inhibition of cell spreading in the presence of 3 ~g/ml 140k. The 
inhibition ofceU spreading is significant at both 20 ~g/ml (P <  0.005) and 90 ug/ml (P <  0.001). 
complex  could  interact directly wiih  f75k  immobilized on 
Sepharose  as judged by affinity column retardation  experi- 
ments. This interaction could be inhibited specifically by the 
addition of the synthetic peptide GRGDS, which contains the 
fibronectin cell  surface  recognition signal.  (c)  The  purified 
140k complex, as might be expected for a  putative receptor, 
competed with cell attachment to fibronectin adsorbed onto 
plastic, as judged by inhibition in cell spreading assays. 
Our study demonstrates the direct binding of a  previously 
identified and characterized membrane antigen to fibronectin. 
Earlier studies reported the localization of the  140k complex 
at the edges of focal contacts, in close contacts and extracel- 
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fibrils  (6-8).  Such  previous  data  suggested  either  of two 
models for the function of 140k: (a) that 140k is a fibronectin 
receptor or (b) that 140k is a structural molecule required for 
the proper placement or function of the fibronectin receptor. 
Our  results  permit  the  conclusion  that  140k  is  a  possible 
fibronectin receptor rather than only a simple structural com- 
plex. 
The inhibition  of direct binding of [3H]f75k to CEF by 
JG22E is consistent with its inhibition of CEF cell spreading 
on fibronectin substrates (7),  and it provides the first direct 
evidence for inhibition of fibronectin-binding activity by such 
an  antibody.  Taken together, these  results strongly suggest 
that the  140k  complex plays a  role in both the binding of 
soluble fibronectin and in the spreading of CEF on immobi- 
lized fibronectin, consistent with its putative role as a fibro- 
nectin receptor. 
That the apparent affinity of 140k for fibronectin is rela- 
tively low is not entirely unexpected. The fibronectin receptor 
on baby hamster kidney cells is of only moderate affinity (Kd 
10  .7 M, references 1 and 3). A high affinity receptor might 
be inconsistent with the biological role of a  ligand such as 
fibronectin that  is involved with cellular processes such  as 
migration, which requires the repeated making and breaking 
of bonds.  The  experiments reported here do  not  permit a 
direct  determination  of the  affinity  constant  of  140k  for 
fibronectin. However, from data reported here and elsewhere 
(l,  3,  33),  we can  roughly estimate that the  140k  complex 
binds to fibronectin with an even lower affinity (K4 >  10  .6 
M).  Another  140,000-D  complex termed  CSAT  has  been 
isolated from chick cells with a monoclonal antibody, and its 
characteristics appear to be identical to those of the complex 
isolated  by JG22E  (compare references  5-10,  15,  22,  27). 
Using a different column interaction assay and intact fibro- 
nectin,  that  group  has also  obtained evidence  for a  weak, 
readily reversible interaction with the similar antigen CSAT 
and fibronectin (i 8a). 
To  summarize,  we  have  been  able  to  demonstrate that 
JG22E binds to a fibronectin-binding complex. The interac- 
tion  of this  140k  complex  and  fibronectin  is  specifically 
inhibited by both JG22E and by synthetic peptides modeled 
from the fibronectin sequence. Furthermore, the interaction 
of cells with immobilized fibronectin can also be inhibited by 
purified exogenous 140k. 
A  signifcant  question  that  we  are  unable  to  answer at 
present is the relationship between the different cell surface 
proteins in the size range of 120,000-140,000 D, all of which 
have been implicated in fibronectin-mediated cell adhesion. 
So far, such molecules have been identified on chick cells (5- 
10,  15, 22, 27), hamster cells (4), and human cells (33). In all 
but one case, the approach has been to identify monoclonal 
antibodies that apparently disrupt cell attachment to fibro- 
nectin substrates and then to identify the antigen recognized 
by the antibody. The question is presently unanswerable due 
to the lack of cross-reactivity between different monoclonal 
antibodies.  Concerning  fibronectin receptor activity, in  the 
most direct study to date,  a  human cell surface protein of 
140,000 D was shown to bind relatively tightly to a fibronectin 
cell-binding fragment (33),  although  the  functional  impor- 
tance of this protein to living cells has not yet been demon- 
strated. We have been able to confirm these observations with 
baby hamster kidney cells, but all attempts to isolate a corn- 
parable  molecule  from  chick  cells  by  fibronectin  affinity 
chromatography have failed because of the lower apparent 
affinity (Figs. 2-4 and unpublished data). Since interaction of 
the chick  140k complex with fibronectin is characterized by 
retardation rather than by the firm binding seen with mam- 
malian  cells,  we  suggest  that  these  molecules  are  in  fact 
functionally different, at least in terms of apparent affinities. 
It will be important to determine in the near future the details 
of the differences and similarities between the biological and 
biochemical characteristics of these membrane components 
of similar size. 
Our conclusion that the  140k complex has specificity as a 
fibronectin receptor does not rule out the possibility that the 
140k complex can also act as a receptor for other cell adhesion 
molecules. Synthetic peptides from the fibronectin sequence 
have been found to inhibit  cellular interactions with  other 
adhesion molecules (16,  18, 35; Kennedy, D. W., and K. M. 
Yamada, unpublished data). Other studies have indicated that 
cells may have the potential to use more than one molecule 
in similar adhesion-related functions depending on which are 
availal~le (reviewed in reference 38), It will be of considerable 
interest to determine which of the 140k complexes and other 
cell surface receptors are of high specificity and which have 
the  ability  to  interact  with  a  wider  spectrum  of adhesive 
molecules. 
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